Norland completes sale and becomes Orthometrix:
This article was originally published in Clinica
Norland Medical Systems has completed the sale of its bone densitometry business, for $5 million, to CooperSurgical (see Clinica No 998, p 15). Upon closing the deal, White Plains, New York-based Norland changed its name to Orthometrix.
You may also be interested in...
Draft policy moots crowdfunding for high-cost rare diseases alongside financial support for those "amenable to one-time treatment" but falls way short of some patient groups' expectations.
India’s Hilleman Laboratories says it’s aiming to develop an affordable vaccine that will target pregnant women in low- and middle-income countries to prevent Group B Streptococcus, a potentially fatal infection passed to babies during childbirth.
Chi-Med’s surufatinib has come up trumps in a second trial in neuroendocrine tumors, after the monitoring committee recommended an early halt following achievement of its PFS target in the pancreatic setting.